Utama › Sindrom Kesukaran Pernafasan › New York
Kajian klinikal Sindrom Kesukaran Pernafasan di New York
13 kajian untuk Sindrom Kesukaran Pernafasan sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Buffalo
- Research Site, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450Physiological Effects of Continuous Negative External Pressure for Acute Hypoxemic Respiratory Failure
- NYU Langone Health - Brooklyn Hospital, Brooklyn
- Bellevue Hospital, New York
- NYU Langone Health - NYU Tisch-Kimmel Hospital, New York
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05675345Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
- New York University Grossman School of Medicine, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT05947955Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
- The Trustees of Columbia University in the City of New York, New York
- Montefiore Medical Center, The Bronx
- Maria Farreri Children's Hospital, Valhalla
Mengambil pesertaFasa 3
1 Hour – 24 Hours · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06776783JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
- Montefiore Hospital - Moses Campus, The Bronx
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
- Montefiore Hospital - Moses Campus, The Bronx
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
- Montefiore Hospital - Moses Campus, The Bronx
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
- Montefiore Hospital - Moses Campus, The Bronx
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06703073Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
- NYU Lagone Health, New York
- New York City Health + Hospitals/ Bellevue, New York
- Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06066502Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- Direct Biologics Investigational Site, Flushing
- Direct Biologics Investigational Site, Queens
- Direct Biologics Investigational Site, The Bronx
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 23 Feb 2026 · NCT05354141Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Our Lady of Lourdes Hospital, Binghamton
Mengambil pesertaKajian pemerhatian
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2025 · NCT06122077The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- Mount Sinai West, New York
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2025 · NCT03642002InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
- Sisters of Charity Hospital, Buffalo
Mengambil pesertaFasa 3
29 Weeks – 36 Weeks · Semua jantina · Dikemas kini 30 Mac 2025 · NCT05960929Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.